Zentalis Pharmaceuticals shares owned by Tybourne Capital Management
Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Tybourne Capital Management
from 13F filings
Historical chart of Tybourne Capital Management investment in Zentalis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Zentalis Pharmaceuticals held by Tybourne Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Zentalis Pharmaceuticals by Tybourne Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $19M | 962k | 20.06 |
| 2023-06-30 | $27M | 962k | 28.21 |
| 2023-03-31 | $28M | 1.6M | 17.20 |
| 2022-12-31 | $45M | 2.2M | 20.14 |
| 2022-09-30 | $50M | 2.3M | 21.66 |
| 2022-06-30 | $68M | 2.4M | 28.10 |
| 2022-03-31 | $112M | 2.4M | 46.14 |
| 2021-12-31 | $221M | 2.6M | 84.06 |
| 2021-09-30 | $178M | 2.7M | 66.64 |
| 2021-06-30 | $142M | 2.7M | 53.20 |
| 2021-03-31 | $116M | 2.7M | 43.39 |
| 2020-12-31 | $138M | 2.7M | 51.94 |
| 2020-09-30 | $87M | 2.7M | 32.69 |
| 2020-06-30 | $128M | 2.7M | 48.02 |
More positions owned by Tybourne Capital Management
View all positions for Tybourne Capital Management